High-quality Immune Assessments

Given the growing number of biologics and immune-targeting drugs, the need to measure and predict the risk of adverse drug reactions in patients is urgent. Animal models fail to address questions related to both safety and effect – resulting in project delays, increased costs, and, above all, a non-optimized clinical program with inherent risks for trial participants.

We combine our strong scientific knowledge with a versatile preclinical platform  – thereby addressing important questions related to the safety and function of biopharmaceuticals.

 

Customize your project

Every drug development project comes with its own needs and challenges. At Immuneed, we provide our customers with a tailored solution in the early stages of development, enabling safe and effective drugs. All projects are fully customized and delivered in a flexible scientific report.

We’re happy to answer questions and get you acquainted with Immuneed – contact us today.

Customer promise

CostSaving

QUALITY:

Quality is reflected in everything we do. With ID.Flow's high predictive value, the platform brings you results that are relevant, reliable and reproducible.

Time

TIME:

We compete not only on the quality and accuracy of data, but also on the speed of achieving it – which is why innovative biotech and agile pharma companies rely on us to ease their transition into the clinic.

Flexibility

FLEXIBILITY:

We tailor the study design based on your specific needs. You choose the number of read-outs, test substances and the level of reporting: “Brief, Standard or Tailored”.

IMMUNEED

I can only recommend Immuneed. We performed a PBMC proliferation study and they delivered high-quality data and the report in a timely manner.
Associate Director, Immunotoxicology – Non-Clinical Safety, Non-Clinical Development & Bioanalysis
Ascendis Pharma
With Immuneed’s ID.Flow, a single platform gives us multiple readouts which provide us with a solid understanding of cytokines, complement, and drug biodistribution.
Prinicpal Scientist at Bioarctic Neuroscience
Bioarctic
Immuneed is a highly appreciated partner and has very short and flexible lead times, usually around 5 weeks. Adding the high sensitivity and reproducibility of the loop in assessing cytokine release and cell activation, we have chosen to use it as a routine in our preclinical development.
Director of Translational Medicine
Affibody